pLenti CMV/TO V5-LUC Puro (w549-1) Citations (3)

Originally described in: A versatile viral system for expression and depletion of proteins in mammalian cells.
Campeau E, Ruhl VE, Rodier F, Smith CL, Rahmberg BL, Fuss JO, Campisi J, Yaswen P, Cooper PK, Kaufman PD. PLoS One. 2009 Aug 6;4(8):e6529. PubMed Journal

---

Articles Citing pLenti CMV/TO V5-LUC Puro (w549-1)

Articles
PI3K-targeting strategy using alpelisib to enhance the antitumor effect of paclitaxel in human gastric cancer. Kim KJ, Kim JW, Sung JH, Suh KJ, Lee JY, Kim SH, Lee JO, Kim JW, Kim YJ, Kim JH, Bang SM, Lee JS, Kim HK, Lee KW. Sci Rep. 2020 Jul 23;10(1):12308. doi: 10.1038/s41598-020-68998-w. PubMed
RNA expression of 6 genes from metastatic mucosal gastric cancer serves as the global prognostic marker for gastric cancer with functional validation. Suh YS, Lee J, George J, Seol D, Jeong K, Oh SY, Bang C, Jun Y, Kong SH, Lee HJ, Kim JI, Kim WH, Yang HK, Lee C. Br J Cancer. 2024 May;130(9):1571-1584. doi: 10.1038/s41416-024-02642-6. Epub 2024 Mar 11. PubMed
Pertuzumab Enhances the Antitumor Activity of T-DXd in HER2-Positive Gastric Cancer Cells. Kang M, Kim KJ, Oh HJ, Sung JH, Nam M, Park BR, Hwang SH, Jung EH, Suh KJ, Kim JW, Kim SH, Kim JW, Kim YJ, Kim JH, Lee KW. Mol Cancer Ther. 2026 May 4;25(5):814-826. doi: 10.1158/1535-7163.MCT-24-0453. PubMed

If you have published an article using this material, please email us at to have your article added to this page.